Weight regain after significant weight loss may be particularly harmful to physiological and psychosocial health
However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower
Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking
The two isomers have opposing pharmacological profiles: enclomiphene is a pure estrogen receptor antagonist centrally, while zuclomiphene has partial agonist activity that can suppress the HPG axis
External resources Exploratory trial of intranasal GLP-1 administration in type 2 diabetes (Diabetes Care) Evaluation of recent intranasal drug delivery systems to the CNS (PMC) Versatile nasal application of cyclodextrins: excipients and actives (PMC) For researchers serious about exploring alternative retatrutide delivery routes, SeekPeptides offers comprehensive protocol databases, dosing calculators, and a community of experienced researchers who have navigated these exact questions
New England Journal of Medicine, 375 (24), 23592370